Tg Therapeutics (TGTX) Interest Expenses (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Interest Expenses of $7.7 million for Q1 2026, up 13.45% year-over-year from $6.8 million in Q1 2025, and up 89.05% quarter-over-quarter from $4.1 million in Q4 2025.
Tg Therapeutics (TGTX) Interest Expenses (2011 - 2026) Analysis & Trends
Tg Therapeutics' Interest Expenses history runs 15 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 13.45% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $25.2 million (up 58.0% YoY), while the FY2025 annual figure was $96.7 million, down 6.77% from the prior year.
- Interest Expenses for Q1 2026 stood at $7.7 million, up from $4.1 million in the prior quarter.
- The five-year high for Interest Expenses was $17.3 million in Q2 2022, with the low at -$1.9 million in Q4 2022.
- The 5-year median for Interest Expenses is $6.7 million (2025), against an average of $7.4 million.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses tumbled 164.08% in 2022, then jumped 407.28% in 2024.
- Tg Therapeutics' Interest Expenses stood at -$1.9 million in 2022, then surged by 357.01% to $4.8 million in 2023, then plunged by 68.96% to $1.5 million in 2024, then soared by 169.79% to $4.1 million in 2025, then soared by 89.05% to $7.7 million in 2026.
- Business Quant data shows TGTX's Interest Expenses at $7.7 million in Q1 2026, $4.1 million in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 16.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.57 Mn |
| Jun 30, 2026 | 16.57 Mn |
| Mar 31, 2026 | 7.67 Mn |
| Mar 31, 2026 | 7.67 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 11.06 Mn |
| Sep 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | 6.72 Mn |
| Jun 30, 2025 | 6.72 Mn |
| Mar 31, 2025 | 6.76 Mn |
| Mar 31, 2025 | 6.76 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Jun 30, 2024 | 13.83 Mn |
| Jun 30, 2024 | 13.83 Mn |
| Mar 31, 2024 | 14.43 Mn |
| Mar 31, 2024 | 14.43 Mn |